Rapport Therapeutics, Inc. RAPP Q2 2025 earnings
Reported August 7, 2025 · Before market open
EPS estimate-$0.87
Next report
Aug 6, 2026 (in a month)Revenue estimate$2.2M
EPS estimate-$0.96
Financials
Q2 2025Valuation & ratios
Versus estimates
Revenue
Diluted EPS
Ask the moment Rapport Therapeutics, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Rapport Therapeutics, Inc. report Q2 2025 earnings?
- Rapport Therapeutics, Inc. (RAPP) reported Q2 2025 earnings on August 7, 2025 before market open.
- What were Rapport Therapeutics, Inc.'s Q2 2025 revenue and EPS?
- Rapport Therapeutics, Inc. reported diluted EPS of $-0.75 for Q2 2025.
- Did Rapport Therapeutics, Inc. beat estimates in Q2 2025?
- EPS beat the consensus estimate of $-0.87 by $0.12.
- How did Rapport Therapeutics, Inc.'s Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, diluted EPS grew 55.9% from $-1.70.
- Where can I find Rapport Therapeutics, Inc.'s Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0000950170-25-104565) directly on SEC EDGAR. The filing index links above go to sec.gov.